{"name":"Stamford Pharmaceuticals, Inc.","slug":"stamford-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSEpYNmozQ3p1b1FnWGdmUWpDaWVMVU53QXREcHBHZEZKazZxR2tmdVI4ekp0TmliMjVDQWNJaGZaNVBnOEtYN3NoRzBBNnk0M25VbUFlNExXUzBramZqNXhXYUtQYzZKcTNUWXZrN29oS2VyeHdZXzQyLS1keDUxOHVDRURiX1BfNVBEa2NoMWk?oc=5","date":"2026-01-06","type":"deal","source":"The Business Journals","summary":"Sacramento pharmaceutical manufacturer Nivagen acquired by private equity-backed PAI Pharma - The Business Journals","headline":"Sacramento pharmaceutical manufacturer Nivagen acquired by private equity-backed PAI Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPTmhxaDdQVGplazVBRVYzV2tlVHVTUGVEdlN2WmtLd1dCclBJREVfbU5Sby1qRVQyZGVnMFAzRWJha3p4RGlXRjRYYWx0NHU2S2k5aV9CWjVoanRRcWV2QzZFcHFTX3hJWEI0b3VSSDBSQlQ2VU9FazdzbDBVeEZyLXUxYzVSdFk1RnFsVXM3VUE4RmJaV2FXME1XczBuaS1PRERlMzlicWF1MWp6ZEllQ3NLd0JZMHB4MXN2aGtaVm5iMk5WRXVDOTJZeVRTVElNNUpBLWd2T0NVb2Z5M1dRMmF5aXZWTkFZNTU1NVV3dVdKRUpOS3FSMG1pS3B4UkZRR0FERUJQbndLeno3WTlJTmtEWC1mNVdsXzNCQ25aUzFlUU5lU01jV2F3VVVNYjVMcnh3VDJpUzRrclQ5?oc=5","date":"2025-12-04","type":"regulatory","source":"PR Newswire","summary":"Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approvals and Expanding Patient Pool | DelveInsight - PR Newswire","headline":"Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approva","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPclltRTVXTUY1Q0FJdm5QZEtldU5mU0dKLW40NFd5NGgzMkplTG1QZnRjWk9WNE1IU2Yta2UyakNSWHZjNUJoMGlJN01TUF90dnBiLW1COVgtSW1PdXdsTnBmMmtEZ29aUEhLdW5lS0R4ZkhRcXZ5MXd6U01EYzlGLWphTWtHVjJVWWE5SkRUVkdadE0xSmh4U1dsb2I2dHFGZVE?oc=5","date":"2025-11-10","type":"regulatory","source":"Stamford Advocate","summary":"FDA announces recall of common ADHD drug prescribed in CT and nationwide - Stamford Advocate","headline":"FDA announces recall of common ADHD drug prescribed in CT and nationwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPekdqd0ZLQ3J3NXdXcHQ0NnFTR2ViQ0pyZEZaakVleWMtTVBhb0RuM1VCR2thT0pzb2xDZS1iQXpIWjg4S0tZVThMSmFCdndERG81VU1VMDVxZjMycmlSV1ZTTkV5bWhyY2JtZ2htSV9uNWpiX040SkFpWnFKN1RmWUtmT29qUFhJ?oc=5","date":"2025-09-10","type":"trial","source":"Yahoo Finance","summary":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance","headline":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Ent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNM1pOa3IwTUxodktJck4xQTBSY0JWMGx1cmdQTldsSnV5LXROQ1R0MzZ4b2xVUGdXTzQ5YWVvSFdYSmlXOHhacVdfTHlTZGc4My1HYlBLSXZRWW9TdHBuWjgzTm9DU2gyQW5lWUpnN1dfc2RYUEViVWJSUzFPUGx2TGZHbzltZVlHblVMVUhPQWRwSktLSVhJVlBUdTJFTGFJd1pn?oc=5","date":"2025-07-31","type":"deal","source":"DCAT Value Chain Insights","summary":"Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025 - DCAT Value Chain Insights","headline":"Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPRXdqRmx0LXZ1dGFYT0trOEVRYzZqdm9XZDZJNU5JYlpQWWs1Ql9wam9yQ1BDYXVrMmR6NzdUSjVYVXBTbjMtOEo1QlNqZzczbU9ZZ0lVNDJWZ2RYOHZTYmlNWjF2aTdjY09VNmZfZWlrTTBkak9ZNmRTQ2JLYjRyNjNxMjVMYnN5cEtSZWZ3T0YzRlpHQVlSemVXREtXUQ?oc=5","date":"2025-04-30","type":"pipeline","source":"CT Insider","summary":"Stamford-based drug developer for rare cancers and tumors sold for $3.9 billion to German company - CT Insider","headline":"Stamford-based drug developer for rare cancers and tumors sold for $3.9 billion to German company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQTVdhTFFmckVuMkJYSDJrQ2FyQ01jWm5SMGVITVRKSDBXVlZQMUQ0LTdkUFl1b3AtTG15bWU4LWlqY0lSTlkwUnlneUFJZkstOXlSNFFFMC04ZEZMWGJpdXl0dnludlBubDNoLUdSNjlqS09DY280eU1hUE1YNDZSQW9zYlNwMjNXcnc4RHJoWEZVZjhRVk1CVmk1RllWX1k2ZE9laktTN1QzVU11Y0VCUUpqZXVXQjFKcUVKdlA4VUJweXlv?oc=5","date":"2025-01-24","type":"pipeline","source":"NPR","summary":"Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over OxyContin - NPR","headline":"Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over OxyContin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNeDhTU1JhMFN5WEoybGxEY2UyYzd0NWF5eHp0ZVJXUVFEWU9jLWtyVDFTU2tCbHQ3VkRuY2Y3S1dTVDZSdG9BQUtRaHJFWHNuZEZMNmt3NmhtaXhrQ0hPeTZOeEhRYThRcDhYR202X24waEZwLURhNHl2UXJMcklleHZ1Y2lIaG1mbXl1RjV4am5Jd1V0MS0tYzRrc2o2LXRvdG1UTA?oc=5","date":"2024-12-18","type":"pipeline","source":"Hartford Business Journal","summary":"Stamford’s Cara Therapeutics to merge with Houston biopharma firm - Hartford Business Journal","headline":"Stamford’s Cara Therapeutics to merge with Houston biopharma firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQVHZSSUd3NmtZdmpZcFhUSTh3N3U2U2hMUE11d0IwMUpnSU05Q3h4bHpGc3dYR1ozRWRaM0dTeDBZdWJWekQtZzRoUlZzc1JfXzc4STZVR05DeGJtUlRvTkQ4RExmVUlzdFRnQ3NhWUpPR2g3S3VCcFdEUU0wbHhyMXkyeFJVcTI1ZVNoX3VFMW9rRmxOMnNTMTJiMzY2ek0wVkpOaEpLbzFNdENGaW01MV80OU1nLXlHMUZiOGY5YnhxTF9tTlcwZ1dQV0dac0Y0VFlOaE8zWHo0YUw4alBZT0V6dExwMWVCVG1NYWR3TGFBY3did0RHUkRQd3lwcUlmVmhJcjVIbHRCZjB5RXVNWk8ydU5VTUp3c3VDc2M3eUxZYUN1VlhmQmFMUkVpaUFnVDE3bDlZc1djZEZmMUlTUg?oc=5","date":"2024-04-11","type":"trial","source":"PR Newswire","summary":"Stamford Pharmaceuticals Inc Announces the First Patient to Be Treated with SP-002 in Combination with Erivedge® in a Phase 2 Study in Locally Advanced BCC Subjects - PR Newswire","headline":"Stamford Pharmaceuticals Inc Announces the First Patient to Be Treated with SP-002 in Combination with Erivedge® in a Ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNbTIwSUZfRWl0M1RIX2RCZnBLbkpJbFk0UmktNHFZeVlZaEI2LWlBdW5UVzFXcHJUT1EtSFMyYVRMc3dKdkE5Y3BPTkhibEZBRXU3QndrNkdSQ2UtSTVKTUNyR0JzSFUwVHNyU003eHJiTURuMU9kUlZqZ0RJRlZjSzBkQkdwTnhpbzlwUzJBakluWnJKNFd5eTFGaEhOb0d6cmwxQQ?oc=5","date":"2018-12-20","type":"pipeline","source":"CTPost","summary":"Connecticut sues Stamford drug maker over opioids - CTPost","headline":"Connecticut sues Stamford drug maker over opioids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPOHVFUmNiWU4welRScDZObW1LZnhPcXFkVEhNYUpuLWhaLW9POGtiSUhGdjJqbFluUkI4cVBJaTE3Vl9UOWZBNnVTYjhsREhORDQ4Q0YyYnB0VHZpLTB2aEE2UTZ0LURrODctVzBsRHl6XzJaYzV1VVdlbDJMM1cyaFFLczE5SUFsTlVvTHhNVHI3S2lrUlMzM3o4bUhQclZNMGt0OHA4WjZxTGJCS3dzYVViRzE3TFRzMG5tTUk2QkRTTGF2M3FxcjR2Nzd1bHZNQmhLWWVOdmp1QQ?oc=5","date":"2018-05-15","type":"pipeline","source":"Attorney General (.gov)","summary":"AG Paxton Announces Lawsuit Against Major Opioid Manufacturer Purdue Pharma for Violation of Texas Deceptive Trade Practices Act - Attorney General (.gov)","headline":"AG Paxton Announces Lawsuit Against Major Opioid Manufacturer Purdue Pharma for Violation of Texas Deceptive Trade Pract","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQUdTSGl5V29oQlRGR2lfcVNjcElDVnA3WUJZWlFqaVUwSG1LUGVtVTZTa2ZwMUtKam5HTTNLbzdkRXVRRFMwVjBrTUpxWlZHWlZoM0J4WEZwWW9XQTN1bldvZG5QLWJvUjZnZmRPQnAtcjdBSkFqYXlFVS1HUlFRb2hBSHV4bU0wY3RydHhuaW5vQ1Zoanp6YzI2dEZqZHU2MFM4SVZ6M3JSUQ?oc=5","date":"2015-11-19","type":"pipeline","source":"Clinical Leader","summary":"Purdue Pharma L.P. Announces The Appointment Of Alan W. Dunton, M.D. To Senior Vice President Of Research & Development - Clinical Leader","headline":"Purdue Pharma L.P. Announces The Appointment Of Alan W. Dunton, M.D. To Senior Vice President Of Research & Development","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}